Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

More eyeballs on AERS

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Scatter plot showing PPRs of adverse events reported for cerivastatin within AERS compared with all AEs reported for all other drugs.


  1. Anonymous. Nat. Biotechnol. 27, 297 (2009).

  2. Codd, E.F. Commun. ACM 13, 377–387 (1970).

    Article  Google Scholar 

  3. Berners-Lee, T., Masinter, L. & McCahill, M. (eds.) Uniform Resource Locators (URL), December 1994.

    Book  Google Scholar 

  4. Almenoff, J.S., LaCroix, K.K., Yuen, N.A., Fram, D. & DuMouchel, W. Drug Saf. 29, 875–887 (2006).

    Article  CAS  Google Scholar 

  5. Furberg, C.D. & Pitt, B. Curr. Control. Trials Cardiovasc. Med. 2, 205–207 (2001).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Ethics declarations

Competing interests

L.A.P. and P.N.D. are founders of the organization providing the search-engine FDAble LLC.

Supplementary information

Supplementary Text and Figures

Supplementary Analysis (PDF 211 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pratt, L., Danese, P. More eyeballs on AERS. Nat Biotechnol 27, 601–602 (2009).

Download citation

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing